APA (7th ed.) Citation

Mendias, C. L., Enselman, E. R. S., Olszewski, A. M., Gumucio, J. P., Edon, D. L., Konnaris, M. A., . . . Bedi, A. (2020). The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial. American Journal of Sports Medicine, 48(8), 1916. https://doi.org/10.1177/0363546520920591

Chicago Style (17th ed.) Citation

Mendias, Christopher L., et al. "The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial." American Journal of Sports Medicine 48, no. 8 (2020): 1916. https://doi.org/10.1177/0363546520920591.

MLA (9th ed.) Citation

Mendias, Christopher L., et al. "The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial." American Journal of Sports Medicine, vol. 48, no. 8, 2020, p. 1916, https://doi.org/10.1177/0363546520920591.